JW (Cayman) Therapeutics Co. Ltd
JWCTF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$84.24M
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $84.24 Million |
|---|---|
| Enterprise Value | $-36,425,791.00 |
| Earnings per Share | $-1.33 |
| Beta | 1.9 |
| Outstanding Shares | 416,597,000 |
Return
| Return on Equity | -210.28% |
|---|---|
| Return on Assets | -114.18% |
| Return on Invested Capital | -116.58% |
Valuation & Multiples
| P/E Ratio | -2.53 |
|---|---|
| PEG | 3.11 |
| Price to Sales | 0.2 |
| Price to Book Ratio | 0.2 |
| Enterprise Value to Revenue | 1.88 |
| Enterprise Value to EBIT | -1.44 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | 0.31 |
| Debt to Equity | 0.6 |
Revenue Sources
No data
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateNext Earnings Call
Expected Date
April 1, 2027
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About JW (Cayman) Therapeutics Co. Ltd
303 employees
CEO: Tian Feng
JW (Cayman) Therapeutics Co. Ltd is a clinical-stage biotechnology company dedicated to the development, manufacture, and commercialization of cell-based immunotherapies. The company primarily targets hematological cancers and solid tumo...